Explore 3 Stock Ideas & Industry Insights Download Free Report

blue-chip

Growth Model Portfolio Rebalancing EXIT (NASDAQ: GOOGL) and ENTRY (NYSE: CNMD)

Feb 05, 2025 | Team Kalkine
Growth Model Portfolio Rebalancing EXIT (NASDAQ: GOOGL) and ENTRY (NYSE: CNMD)
Image source: shutterstock

  • GOOGL:NASDAQ
  • Investment Type
    Large-cap
  • Risk Level
  • Action
  • Rec. Price (US$)
  • CNMD:NYSE
  • Investment Type
    Mid - Cap
  • Risk Level
  • Action
  • Rec. Price (US$)

1. Exit Case: Alphabet Inc (NASDAQ: GOOGL)

Overview: Alphabet Inc. (NASDAQ: GOOGL) is a holding company. The Company's segments include Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube.

GOOGL has been a part of the ‘Growth Model Portolio’ since 19th September 2024, however, considering the recent rally, trading near the resistance in the stock, support & resistance levels, and ~27.29% upside from the entry price, an ‘Exit’ is recommended from the stock near the resistance of USD 206.38, as on (04th February 2025).

Alphabet Inc (NASDAQ: GOOGL) part of Kalkine’s US Growth Model Portfolio, has reached near its resistance level around which an exit case emerges.

1.1 Support and Resistance Summary as provided in our last published report dated 19th September 2024.

1.2 Alphabet Inc (NASDAQ: GOOGL)

2. New Entry Case: CONMED Corporation (NYSE: CNMD)

Overview: CONMED Corporation is a medical technology company, which provides surgical devices and equipment for minimally invasive procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. 

Technical Analysis: The Relative Strength Index (RSI) over a 14-day period stands at a value of 60.03, upward trending, with expectations of a consolidation or an upward momentum once USD 75-USD 80 resistance is broken on the upside. Additionally, the stock's current positioning is above both the 50-period SMA and 200-period SMA, which may serve as dynamic short to medium-term support levels.

Considering the above mentioned factors, technical analysis, support & resistance levels, key risks and outlook an ‘Entry’ is recommended in the ‘Growth Model Portfolio’ at the closing market price of USD 72.88, as of February 04, 2025.

2.1 Support and Resistance Summary as on 04th February 2025

2.2 One Year Technical Price Chart (NYSE: CNMD)

Note 1: Past performance is neither an Indicator nor a guarantee of future performance.

Note 2: The reference date for all price data, and currency as of (04thFebruary 2025). The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings.

Disclaimer

This information should not be relied upon as personal financial advice by Kalkine on (i) the stocks or (ii) the use or suitability of the model portfolios. Only an investor knows about their circumstances to make an investment decision.

Model Portfolio has been prepared for illustrative purpose only and does not consider the objectives, financial situation or needs of any investor. Accordingly, investors should, before acting on the information, consider its appropriateness, having regard to their objectives, financial situation and needs. Past performance is not necessarily indicative of future performance results. Actual investment returns will vary, and the value of investments can go up or down.


Disclaimer-

Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions  and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.

Past performance is not a reliable indicator of future performance.